FR1450840A - Process for the preparation of new 9beta, 10alpha-steroids - Google Patents
Process for the preparation of new 9beta, 10alpha-steroidsInfo
- Publication number
- FR1450840A FR1450840A FR25070A FR25070A FR1450840A FR 1450840 A FR1450840 A FR 1450840A FR 25070 A FR25070 A FR 25070A FR 25070 A FR25070 A FR 25070A FR 1450840 A FR1450840 A FR 1450840A
- Authority
- FR
- France
- Prior art keywords
- 9beta
- 10alpha
- steroids
- preparation
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F5/00—Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
- C02F5/08—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
- C02F5/10—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR25070A FR1450840A (en) | 1965-07-19 | 1965-07-19 | Process for the preparation of new 9beta, 10alpha-steroids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR25070A FR1450840A (en) | 1965-07-19 | 1965-07-19 | Process for the preparation of new 9beta, 10alpha-steroids |
GB3054865A GB1095665A (en) | 1965-07-19 | 1965-07-19 | Novel 9ª‰, 10ª‡-steroids and a process for the manufacture thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
FR1450840A true FR1450840A (en) | 1966-06-24 |
Family
ID=26164847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR25070A Expired FR1450840A (en) | 1965-07-19 | 1965-07-19 | Process for the preparation of new 9beta, 10alpha-steroids |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR1450840A (en) |
-
1965
- 1965-07-19 FR FR25070A patent/FR1450840A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH468425A (en) | Process for the preparation of new polyamides | |
CH461500A (en) | Process for the preparation of new isoindolinosulfonylureas | |
FR1482577A (en) | Process for the preparation of beta-alkyl-alpha, omega-diaminoalkanes | |
FR1505657A (en) | Process for the preparation of substituted diphenylalkylamines | |
FR1512869A (en) | Process for the preparation of new propynyl ethers | |
CH481115A (en) | Process for the preparation of new cinnamylpiperazines | |
FR1446515A (en) | Process for the preparation of new 9beta, 10alpha-steroids | |
CH480318A (en) | Process for the preparation of 7a-methyl gona-4,9-dienes | |
CH474516A (en) | Process for the preparation of new 2,6-dihalo-isonicotinamides | |
FR1503599A (en) | Process for the preparation of new 3-amino-cholestanes | |
FR1499544A (en) | Process for the preparation of 11beta-hydroxy-9,10alpha-seroids | |
CH485626A (en) | Process for the preparation of new phenols | |
FR1491587A (en) | Process for the preparation of new 19-nor-androstatrienes | |
FR1513463A (en) | Process for the preparation of new tri-iodo-diaminobenzenes | |
FR1510878A (en) | Process for the preparation of benzindenes | |
FR1443577A (en) | Process for the preparation of new 9beta, 10alpha-steroids | |
FR1452696A (en) | Process for the preparation of new 9beta, 10alpha-steroids | |
FR1450840A (en) | Process for the preparation of new 9beta, 10alpha-steroids | |
FR1459000A (en) | Improved process for the preparation of trioxane | |
FR1463725A (en) | Process for the preparation of new imidazoles | |
OA02517A (en) | Process for the preparation of tritylamines. | |
FR1404481A (en) | Process for the preparation of novel 3-ethers of nu- (alpha, gamma-dihydroxy-beta, beta-dimethyl-butyryl) -propylamine | |
FR1502714A (en) | Process for the preparation of 1, 2-epoxy-9beta, 10alpha-steroids | |
FR1491588A (en) | Process for the preparation of new 7-methyl-19-nor-androstadienes | |
FR1494371A (en) | Process for the preparation of 5beta-eta-6-keto-steroids |